- Home
- PLX vs FTLF Comparison
PLX vs FTLF Comparison
Compare PLX & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLX
- FTLF
- Stock Information
- Founded
- PLX 1993
- FTLF 2005
- Country
- PLX Israel
- FTLF United States
- Employees
- PLX N/A
- FTLF N/A
- Industry
- PLX Biotechnology: Biological Products (No Diagnostic Substances)
- FTLF Medicinal Chemicals and Botanical Products
- Sector
- PLX Health Care
- FTLF Health Care
- Exchange
- PLX Nasdaq
- FTLF Nasdaq
- Market Cap
- PLX 160.2M
- FTLF 150.4M
- IPO Year
- PLX 1998
- FTLF N/A
- Fundamental
- Price
- PLX $2.33
- FTLF $32.54
- Analyst Decision
- PLX
- FTLF Strong Buy
- Analyst Count
- PLX 0
- FTLF 1
- Target Price
- PLX N/A
- FTLF $40.00
- AVG Volume (30 Days)
- PLX 553.9K
- FTLF 9.1K
- Earning Date
- PLX 03-13-2025
- FTLF 02-20-2025
- Dividend Yield
- PLX N/A
- FTLF N/A
- EPS Growth
- PLX N/A
- FTLF 93.67
- EPS
- PLX N/A
- FTLF 1.70
- Revenue
- PLX $45,667,000.00
- FTLF $62,755,000.00
- Revenue This Year
- PLX N/A
- FTLF $25.54
- Revenue Next Year
- PLX $90.00
- FTLF $7.30
- P/E Ratio
- PLX N/A
- FTLF $19.13
- Revenue Growth
- PLX N/A
- FTLF 40.17
- 52 Week Low
- PLX $0.82
- FTLF $20.87
- 52 Week High
- PLX $2.36
- FTLF $35.49
- Technical
- Relative Strength Index (RSI)
- PLX 78.72
- FTLF 54.69
- Support Level
- PLX $2.11
- FTLF $29.40
- Resistance Level
- PLX $2.36
- FTLF $32.70
- Average True Range (ATR)
- PLX 0.12
- FTLF 0.95
- MACD
- PLX 0.00
- FTLF 0.17
- Stochastic Oscillator
- PLX 94.23
- FTLF 68.26
About PLX Protalix BioTherapeutics Inc. (DE)
Protalix BioTherapeutics Inc is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx protein expression system or ProCellEx. It has developed taliglucerase alfa for the treatment of Gaucher disease. The company's products also treat diseases like Fabry disease and cystic fibrosis. The company's primary sources of revenue include its sales of BioManguinhos alfataliglicerase in Brazil and of drug substances to Pfizer under its Amended Pfizer Agreement. The company's pipeline consists of ELFABRIO, Uricase, and Long Acting DNase I.
About FTLF FitLife Brands Inc.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, and sports drink products, meal replacement products and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products and Supplements.